Form 6-K Biofrontera AG For: Jun 23
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2021
Commission File Number: 001-38396
BIOFRONTERA AG
(Registrant’s name / Translation of registrant’s name into English)
Hemmelrather Weg 201, D-51377 Leverkusen Germany
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [X] Form:40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): N/A
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): N/A
EXHIBITS
Exhibit Number | Description | |
99.1 | Biofrontera AG: Release according to Article 40, Section 1 of the WpHG |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
BIOFRONTERA AG | ||
By: | /s/ Hermann Lübbert | |
Name: | Hermann Lübbert | |
Title: | Chief Executive Officer |
Date: June 23, 2021
Exhibit 99.1
Biofrontera AG: Release according to Article 40, Section 1 of the WpHG
Release according to article 40 para. 1 WpHG
Leverkusen, Germany (pta/23.06.2021/19:30) - Release of Voting Rights Announcement
Voting Rights Announcement
1. Details of issuer:
Name: | Biofrontera AG |
Legal Entity Identifier (LEI): | 391200D6GFSVFGFQTL13 |
Street: | Hemmelrather Weg 201 |
Postal code: | 51377 |
City: | Leverkusen, Germany |
2. Reason for notification:
Voluntary group notification due to threshold contact of a subsidiary
3. Details of person subject to the notification obligation
Natural person (first name, surname): Wilhelm K. T. Zours
Date of birth: 1961-07-28
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3
- DELPHI Unternehmensberatung Aktiengesellschaft
- Deutsche Balaton Aktiengesellschaft
- SPARTA AG
- Deutsche Balaton Biotech AG
5. Date on which threshold was crossed or reached
17.06.2021
6. Total positions
% of voting rights attached to shares (total of 7.a.) | % of voting rights through instruments (total of 7.b.1 + 7.b.2) | Total of both in % (7.a. + 7.b.) | Total number of voting rights pursuant to Sec. 41 WpHG | |||||||||||||
New | 29.96 | 3.09 | 33.04 | 56,717,385 | ||||||||||||
Previous notification (if applicable) | 29.96 | 1.76 | 31.72 |
7. Details on total positions
a. Voting rights attached to shares (Sec.s 33, 34 WpHG)
ISIN | Absolute direct (Sec. 33 WpHG) | Absolute indirect (Sec. 34 WpHG) | In % direct (Sec. 33 WpHG) | In % indirect (Sec. 34 WpHG) | ||||||||||||
DE0006046113 | 0 | 16,990,199 | 0.00 | 29.96 | ||||||||||||
Total: | 16,990,199 | 29.96 |
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument | Maturity / Expiration | Exercise or conversion period | Voting Rights Absolute | Voting Rights in % | ||||||||||||
0 | 0.00 | |||||||||||||||
Total: | 0 | 0.00 |
b.2 Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument | Maturity / Expiration | Exercise or conversion period | Cash or physical transaction | Voting Rights Absolute | Voting Rights in % | |||||||||||||
Convertible bond | 28.12.2022 | 31.03.2021 to 16.12.2022 | Both | 1,750,000 | 3.09 | |||||||||||||
Total: | 1,750,000 | 3.09 |
8. Information in relation to the person subject to the notification obligation
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity
Name | % of voting rights (if at least 3% or more) | % of voting rights through instruments (if at least 5% or more) | Total of both (if at least 5% or more) | |||||||||
- Wilhelm K. T. Zours | ||||||||||||
- DELPHI Unternehmensberatung Aktiengesellschaft | 27.02 | 27.02 | ||||||||||
- Strawtec Group AG | ||||||||||||
- | ||||||||||||
- Wilhelm K. T. Zours | ||||||||||||
- DELPHI Unternehmensberatung Aktiengesellschaft | 27.02 | 27.02 | ||||||||||
- VV Beteiligungen Aktiengesellschaft | ||||||||||||
- Deutsche Balaton Aktiengesellschaft | 27.02 | 30.10 | ||||||||||
- ABC Beteiligungen AG | 27.02 | 27.02 | ||||||||||
- Heidelberger Beteiligungsholding AG | 27.02 | 27.02 | ||||||||||
- | ||||||||||||
- Wilhelm K. T. Zours | ||||||||||||
- DELPHI Unternehmensberatung Aktiengesellschaft | 27.02 | 27.02 | ||||||||||
- VV Beteiligungen Aktiengesellschaft | ||||||||||||
- Deutsche Balaton Aktiengesellschaft | 27.02 | 30.10 | ||||||||||
- SPARTA AG | 27.02 | 27.02 | ||||||||||
- | ||||||||||||
- Wilhelm K. T. Zours | ||||||||||||
- DELPHI Unternehmensberatung Aktiengesellschaft | 27.02 | 27.02 | ||||||||||
- VV Beteiligungen Aktiengesellschaft | ||||||||||||
- Deutsche Balaton Aktiengesellschaft | 27.02 | 30.10 | ||||||||||
- Deutsche Balaton Biotech AG | 29.95 | 29.95 | ||||||||||
- | ||||||||||||
- Wilhelm K. T. Zours | ||||||||||||
- DELPHI Unternehmensberatung Aktiengesellschaft | 27.02 | 27.02 | ||||||||||
- VV Beteiligungen Aktiengesellschaft | ||||||||||||
- Deutsche Balaton Aktiengesellschaft | 27.02 | 30.10 | ||||||||||
- Altech Advanced Materials AG | ||||||||||||
- | ||||||||||||
- Wilhelm K. T. Zours | ||||||||||||
- DELPHI Unternehmensberatung Aktiengesellschaft | 27.02 | 27.02 | ||||||||||
- VV Beteiligungen Aktiengesellschaft | ||||||||||||
- Deutsche Balaton Aktiengesellschaft | 27.02 | 30.10 | ||||||||||
- Ming Le Sports AG |
9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)
Date of general meeting: N/A
10. Other useful information
DELPHI Unternehmensberatung Aktiengesellschaft, Deutsche Balaton Aktiengesellschaft, SPARTA AG, Deutsche Balaton Biotech AG, ABC Beteiligungen AG and Heidelberger Beteiligungsholding AG are parties to a voting agreement dated January 28, 2020.
Date
18.06.2021
(end)
emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: [email protected]
website: www.biofrontera.com
ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Dusseldorf, Frankfurt; free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate
other stock exchanges: Nasdaq
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TabaPay to Acquire the Assets of Synapse Financial Technologies, Inc.
- Atlas Salt Inc. Announces Release with Conditions under the Environmental Protection Act for the Great Atlantic Salt Project
- LS Cable & System Welcomes $99 Million Investment Tax Credit Under Section 48C of the Inflation Reduction Act
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!